UBS analyst AJ Rice raised the firm’s price target on Pediatrix Medical (MD) to $16.50 from $16 and keeps a Neutral rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD:
- Pediatrix Medical sees FY25 adjusted EBITDA $245M-$255M
- Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c
- Pediatrix Medical Group, Inc. (MD) Q2 Earnings Cheat Sheet
- Cautious Optimism: Evaluating Pediatrix Medical Group Amid Shifting Birth Trends
- Pediatrix Medical Group Appoints Dr. Kurt Newman to Board